Personal profile
Education/Academic qualification
3.1 Basic medicine, Expert, Latvian Council of Science
4 Dec 2025 → 3 Dec 2028
3.1 Basic medicine, Expert, Latvian Council of Science
2 Feb 2023 → 1 Feb 2026
3.1 Basic medicine, Expert, Latvian Council of Science
24 Apr 2020 → 23 Apr 2023
1.4 Chemical sciences, Expert, Latvian Council of Science
18 Apr 2015 → 16 Apr 2018
Field of Science
- 3.1 Basic medicine
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
-
SDG 3 Good Health and Well-being
Fingerprint
- 1 Similar Profiles
Collaborations and top research areas from the last five years
-
Therapeutic Drug Monitoring of Olanzapine in Psychiatry: Clinical Aspects and Challenges.
Vircava, A. (Project leader), Urtāne, I. (Supervisor) & Vrubļevska, J. (Project leader)
2/02/26 → 31/01/30
Project: PhD projects
-
Evaluation of the long-term efficacy of combined lipid-lowering therapy in very high cardiovascular risk patients. Latvian data.
Gavrilova, A. (Expert), Lapšovs, M. (Project leader), Urtāne, I. (Expert) & Trušinskis, K. (Leading expert)
1/09/23 → 31/08/25
Project: Projects outside RSU
-
Benefits of an arterial hypertension therapy evaluation model combining laboratory and clinical capabilities in polypharmacy conditions
Stuķēna, I. (Project leader), Trušinskis, K. (Expert) & Urtāne, I. (Expert)
1/04/22 → 31/03/23
Project: RSU grants
-
Analysis of the dynamics of the consumption of state-reimbursed hypolipidemic drugs in Latvia from 2012 to 2021
Praškilēvics, A. (Project leader) & Urtāne, I. (Supervisor)
1/10/21 → 30/09/24
Project: PhD projects
-
Safety issues with direct oral anticoagulant therapy in patients with atrial fibrillation in case of polypharmacy
Gavrilova, A. (Project leader) & Urtāne, I. (Supervisor)
1/10/20 → 3/11/25
Project: PhD projects
-
EFFECTIVENESS OF PCSK9 INHIBITOR TREATMENT IN VERY-HIGH CARDIOVASCULAR RISK PATIENTS
Gavrilova, A., Lapšovs, M., Markova, Z. E., Trušinskis, K. & Urtāne, I., Mar 2025, In: International Journal of Clinical Pharmacy. 47, 2, p. 558 PP139.Research output: Contribution to journal › Meeting Abstract › peer-review
1 Citation (Scopus) -
QUANTITATIVE ASSESSMENT OF DIRECT ORAL ANTICOAGULANT ADHERENCE USING THE PROPORTION OF DAYS COVERED METHOD
Gavrilova, A., Zolovs, M., Šmits, D., Ņikitina, A., Latkovskis, G. & Urtāne, I., Mar 2025, In: International Journal of Clinical Pharmacy. 47, 2, p. 557-558 PP138.Research output: Contribution to journal › Meeting Abstract › peer-review
-
Role of a National Health Service Electronic Prescriptions Database in the Detection of Prescribing and Dispensing Issues and Adherence Evaluation of Direct Oral Anticoagulants
Gavrilova, A. (Corresponding Author), Zolovs, M., Šmits, D., Ņikitina, A., Latkovskis, G. & Urtāne, I., 9 May 2024, In: Healthcare (Basel, Switzerland). 12, 10, 10 p., 975.Research output: Contribution to journal › Article › peer-review
Open AccessFile10 Downloads (Pure) -
Quantitative Adherence Level Evaluation Among Long-Term Antiretroviral Therapy Patients in Latvia
Gavrilova, A. (Corresponding Author), Zolovs, M., Urtāne, I. & Šmits, D., Dec 2023, In: Patient Preference and Adherence. 17, p. 3147-3154 8 p.Research output: Contribution to journal › Article › peer-review
Open AccessFile23 Downloads (Pure) -
National Trends in the Use of State-Reimbursed Lipid-Lowering Medications in Latvia (2012–2021)
Praskilevics, A. (Corresponding Author), Urtane, I. & Latkovskis, G., Oct 2023, In: Journal of clinical medicine. 12, 19, 6390.Research output: Contribution to journal › Article › peer-review
Open AccessFile2 Citations (Scopus)45 Downloads (Pure)
Activities
-
RSU Research week 2025
Brangule, A. (Scientific committee member), Logviss, K. (Scientific committee member), Mauriņa, B. (Scientific committee member), Mohylyuk, V. (Scientific committee member), Urtāne, I. (Scientific committee member) & Jakštas, V. (Scientific committee member)
26 Mar 2025 → 28 Mar 2025Activity: Participating in or organising an event types › Organising a conference, workshop, ...
-
Starptautisko inovatīvo farmaceitisko firmu asociācijas un Latvijas Patentbrīvo medikamentu asociācija (External organisation)
Urtāne, I. (Member)
21 Nov 2024 → 21 Nov 2026Activity: Membership types › Membership of NGOs
-
Female patients with cardiovascular diseases are treated with lower statin doses when used in combination with ezetimibe in Latvia
Praškilēvics, A. (Speaker), Urtāne, I. (Co-author) & Latkovskis, G. (Co-author)
5 Apr 2024Activity: Talk or presentation types › Oral presentation
-
Analysis of antibiotic consumption at the paediatric tertiary-care hospital
Sviestiņa, I. (Speaker) & Urtāne, I. (Co-author)
5 Apr 2024Activity: Talk or presentation types › Poster presentation
-
Rīgas Austrumu klīniskās universitātes slimnīcas atbalsta fonda Medicīnisko un biomedicīnisko pētījumu Ētikas komiteja (External organisation)
Urtāne, I. (Member)
2 Jan 2024 → …Activity: Membership types › Membership of council
Press/Media
-
Līdzestības meklējumos
Kursīte, M., Urtāne, I. & Freimane, G.
14/04/25
1 item of Media coverage
Press/Media
-
Inovēt veidu, kā mācīt un mācīties
Strods, R., Gavrilova, A., Urtāne, I., Blumfelde-Rutka, K. & Feldmane-Jumīte, P.
24/05/23
1 item of Media coverage
Press/Media
-
Inovēt veidu, kā mācīt un mācīties
Gavrilova, A., Urtāne, I., Blumfelde-Rutka, K. & Strods, R.
24/05/23
1 item of Media coverage
Press/Media
-